BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21185294)

  • 21. Expression of pituitary adenylate cyclase activating polypeptide and its type I receptor mRNAs in human placenta.
    Koh PO; Won CK; Noh HS; Cho GJ; Choi WS
    J Vet Sci; 2005 Mar; 6(1):1-5. PubMed ID: 15785117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development.
    Basille M; Vaudry D; Coulouarn Y; Jegou S; Lihrmann I; Fournier A; Vaudry H; Gonzalez B
    J Comp Neurol; 2000 Oct; 425(4):495-509. PubMed ID: 10975876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates.
    Jolivel V; Basille M; Aubert N; de Jouffrey S; Ancian P; Le Bigot JF; Noack P; Massonneau M; Fournier A; Vaudry H; Gonzalez BJ; Vaudry D
    Neuroscience; 2009 May; 160(2):434-51. PubMed ID: 19236905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors in the brain.
    Shioda S
    Kaibogaku Zasshi; 2000 Dec; 75(6):487-507. PubMed ID: 11197592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery.
    Vaudry D; Falluel-Morel A; Bourgault S; Basille M; Burel D; Wurtz O; Fournier A; Chow BK; Hashimoto H; Galas L; Vaudry H
    Pharmacol Rev; 2009 Sep; 61(3):283-357. PubMed ID: 19805477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pituitary adenylate cyclase-activating polypeptide type I receptors mediate cyclic AMP-dependent enhancement of neuronal acetylcholine sensitivity.
    Margiotta JF; Pardi D
    Mol Pharmacol; 1995 Jul; 48(1):63-71. PubMed ID: 7623776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pituitary adenylate cyclase-activating polypeptide stimulates renin secretion via activation of PAC1 receptors.
    Hautmann M; Friis UG; Desch M; Todorov V; Castrop H; Segerer F; Otto C; Schütz G; Schweda F
    J Am Soc Nephrol; 2007 Apr; 18(4):1150-6. PubMed ID: 17360952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of pituitary adenylate cyclase-activating polypeptide (PACAP) on prolactin and somatolactin release from the goldfish pituitary in vitro.
    Matsuda K; Nejigaki Y; Satoh M; Shimaura C; Tanaka M; Kawamoto K; Uchiyama M; Kawauchi H; Shioda S; Takahashi A
    Regul Pept; 2008 Jan; 145(1-3):72-9. PubMed ID: 17920707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptor.
    Bourgault S; Vaudry D; Ségalas-Milazzo I; Guilhaudis L; Couvineau A; Laburthe M; Vaudry H; Fournier A
    J Med Chem; 2009 May; 52(10):3308-16. PubMed ID: 19413310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in pituitary adenylate cyclase-activating polypeptide following renal ischemia-reperfusion in rats.
    Szakaly P; Horvath G; Kiss P; Laszlo E; Farkas J; Furjes G; Nemeth J; Reglodi D
    Transplant Proc; 2010; 42(6):2283-6. PubMed ID: 20692463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GnRH-induced PACAP and PAC1 receptor expression in pituitary gonadotrophs: a possible role in the regulation of gonadotropin subunit gene expression.
    Purwana IN; Kanasaki H; Oride A; Mijiddorj T; Shintani N; Hashimoto H; Baba A; Miyazaki K
    Peptides; 2010 Sep; 31(9):1748-55. PubMed ID: 20553777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pituitary adenylate cyclase-activating polypeptide (PACAP) can act as determinant of the tyrosine hydroxylase phenotype of dopaminergic cells during retina development.
    Borba JC; Henze IP; Silveira MS; Kubrusly RC; Gardino PF; de Mello MC; Hokoç JN; de Mello FG
    Brain Res Dev Brain Res; 2005 May; 156(2):193-201. PubMed ID: 16099306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of pituitary adenylate cyclase-activating polypeptide and pituitary adenylate cyclase-activating polypeptide type I receptor mRNA in the chicken brain.
    Peeters K; Gerets HH; Arckens L; Vandesande F
    J Comp Neurol; 2000 Jul; 423(1):66-82. PubMed ID: 10861537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of pituitary adenylate cyclase activating polypeptides (PACAPs) specific radioimmunoassay systems and distribution of PACAP-like immunoreactivity in guinea pig tissues.
    Ando E; Nokihara K; Naruse S
    Biomed Pept Proteins Nucleic Acids; 1994-1995; 1(1):45-50. PubMed ID: 9346869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.
    Reubi JC; Läderach U; Waser B; Gebbers JO; Robberecht P; Laissue JA
    Cancer Res; 2000 Jun; 60(11):3105-12. PubMed ID: 10850463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.
    Van Rampelbergh J; Gourlet P; De Neef P; Robberecht P; Waelbroeck M
    Mol Pharmacol; 1996 Dec; 50(6):1596-604. PubMed ID: 8967982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PACAP immunoreactivity in human malignant tumor samples and cardiac diseases.
    Szanto Z; Sarszegi Z; Reglodi D; Nemeth J; Szabadfi K; Kiss P; Varga A; Banki E; Csanaky K; Gaszner B; Pinter O; Szalai Z; Tamas A
    J Mol Neurosci; 2012 Nov; 48(3):667-73. PubMed ID: 22648511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral and central alterations of pituitary adenylate cyclase activating polypeptide-like immunoreactivity in the rat in response to activation of the trigeminovascular system.
    Tuka B; Helyes Z; Markovics A; Bagoly T; Németh J; Márk L; Brubel R; Reglődi D; Párdutz A; Szolcsányi J; Vécsei L; Tajti J
    Peptides; 2012 Feb; 33(2):307-16. PubMed ID: 22245521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of PACAP and PAC1 Receptor in Normal Human Thyroid Gland and in Thyroid Papillary Carcinoma.
    Bardosi S; Bardosi A; Nagy Z; Reglodi D
    J Mol Neurosci; 2016 Oct; 60(2):171-8. PubMed ID: 27566169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pituitary adenylate cyclase activating polypeptide (PACAP) in the rat mammary gland.
    Skakkebaek M; Hannibal J; Fahrenkrug J
    Cell Tissue Res; 1999 Oct; 298(1):153-9. PubMed ID: 10555549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.